Overview
-
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
₹39.26
▼ 0.20
(0.52%)
| Instrument Name | Watchlist | Investment Date | % Holding | No of Units | Value (₹ Cr) | Asset Type | Industry Name |
|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical ... | 31 Aug 2026 | 8.43% | 6,65,178 | ₹132.02 Cr | Equity | Pharmaceuticals | |
 Healthcare Global E... | 31 Aug 2026 | 6.30% | 13,44,012 | ₹98.56 Cr | Equity | Healthcare | |
 Divis Laboratories Ltd | 31 Aug 2026 | 5.65% | 93,472 | ₹88.49 Cr | Equity | Pharmaceuticals | |
 Abbott India Ltd | 31 Aug 2026 | 5.44% | 32,924 | ₹85.11 Cr | Equity | Pharmaceuticals | |
 Rainbow Childrens M... | 31 Aug 2026 | 4.47% | 4,95,081 | ₹70.04 Cr | Equity | Healthcare | |
| Apollo Hospitals En... | 31 Aug 2026 | 4.32% | 76,013 | ₹67.64 Cr | Equity | Healthcare | |
 Cipla Ltd | 31 Aug 2026 | 4.27% | 4,73,861 | ₹66.78 Cr | Equity | Pharmaceuticals | |
| Dr Reddys Laborator... | 31 Aug 2026 | 4.21% | 5,70,312 | ₹65.84 Cr | Equity | Pharmaceuticals | |
 Max Healthcare Inst... | 31 Aug 2026 | 3.80% | 5,71,483 | ₹59.55 Cr | Equity | Healthcare | |
 Fortis Healthcare Ltd | 31 Aug 2026 | 3.30% | 5,69,351 | ₹51.63 Cr | Equity | Healthcare |
Funds in the same category by AUM
You can invest in Tata India Pharma & Healthcare Fund - Direct (G) through a lump sum investment or a monthly SIP. The minimum lump sum investment is ₹5,000 and the minimum SIP amount is ₹100.
The latest NAV of Tata India Pharma & Healthcare Fund - Direct (G) is ₹39.26.
Tata India Pharma & Healthcare Fund - Direct (G) manages assets worth ₹1,565.28 Cr.
The expense ratio of Tata India Pharma & Healthcare Fund - Direct (G) is 1.00%.
The exit load applicable on Tata India Pharma & Healthcare Fund - Direct (G) is 0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment..
As per the riskometer, Tata India Pharma & Healthcare Fund - Direct (G) carries Very High risk.
Tata India Pharma & Healthcare Fund - Direct (G) is managed by Tata Mutual Fund.
Tata India Pharma & Healthcare Fund - Direct (G) belongs to the Sectoral Fund category.
Tata India Pharma & Healthcare Fund - Direct (G) is benchmarked against the BSE Healthcare TRI.
Tata India Pharma & Healthcare Fund - Direct (G) has no lock-in period, so units can be redeemed at any time subject to the applicable exit load.
Tata India Pharma & Healthcare Fund - Direct (G) was launched on 28 Dec 2015.
After the initial investment, you can invest in Tata India Pharma & Healthcare Fund - Direct (G) in further multiples of ₹1,000.
To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.
To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.
28 Dec 2015
₹1,565.28 Cr
₹39.26
₹100
₹5,000
Very High
1.00%
14.43
0.77
0.95
4.73
0.62
0.07
99.67
0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment.
This fund has Very High risk.
Returns over a year are annualised (per year, compounded).
Calendar year return from the first period shown through each year.
| Company | Watchlist | Sector | Activity | Investment Date | % Holding | Market Value | Shares | Asset Type | Rating |
|---|---|---|---|---|---|---|---|---|---|
| Aster DM Quality Ca... | Hospitals / Medic... | Bought | 31 Aug 2026 | 1.59% | ₹24.93 Cr | 3,29,708 | Equity | EQUITY | |
| Acutaas Chemicals Ltd | Pharmaceuticals -... | Bought | 31 Aug 2026 | 1.48% | ₹23.20 Cr | 73,399 | Equity | EQUITY | |
 P I Industries Ltd | Pesticides / Agro... | Bought | 31 Aug 2026 | 0.95% | ₹14.95 Cr | 63,066 | Equity | EQUITY | |
 Ipca Laboratories Ltd | Pharmaceuticals -... | Bought | 31 Aug 2026 | 0.90% | ₹14.13 Cr | 71,536 | Equity | EQUITY | |
| Molbio Diagnostics Ltd | Medical Equipment | Bought | 31 Aug 2026 | 0.87% | ₹13.67 Cr | 1,25,804 | Equity | EQUITY | |
| Symbiotec Pharmalab... | Pharmaceuticals -... | Bought | 31 Aug 2026 | 0.64% | ₹10.00 Cr | 1,01,220 | Equity | EQUITY | |
| HDFC Life Insurance... | Life Insurance | Bought | 31 Aug 2026 | 0.50% | ₹7.88 Cr | 1,45,063 | Equity | EQUITY | |
| Reverse Repo | Debt Others | Bought | 31 Aug 2026 | 0.19% | ₹3.03 Cr | 0 | Reverse Repo | UR / N.A. | |
 Torrent Pharmaceuti... | Pharmaceuticals -... | Bought | 31 Aug 2026 | 0.12% | ₹1.89 Cr | 3,740 | Equity | EQUITY | |
| Concord Biotech Ltd | Pharmaceuticals -... | Sold | 31 Jul 2026 | 1.91% | ₹29.46 Cr | 2,07,380 | Equity | EQUITY |
Funds in the same category by AUM
| Fund | Watchlist | AMC | NAV | Fund Size | Expense Ratio | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
 ICICI Pru Technology Fund... | ICICI Prudential Mutual Fund | ₹194.12 | ₹13,660.98 Cr | 1.22% | -11.08% | 4.46% | 1.93% | |
 HDFC Defence Fund - Direc... | HDFC Mutual Fund | ₹31.08 | ₹11,477.59 Cr | 0.89% | 23.83% | 38.03% | — | |
| ICICI Pru Banking & Finan... | ICICI Prudential Mutual Fund | ₹145.07 | ₹11,330.58 Cr | 1.23% | -3.67% | 9.21% | 8.98% | |
 SBI Banking & Financial S... | SBI Mutual Fund | ₹47.70 | ₹10,872.95 Cr | 1.20% | -0.70% | 14.93% | 11.76% | |
| Tata Digital India Fund -... | Tata Mutual Fund | ₹46.47 | ₹10,322.02 Cr | 0.67% | -13.66% | 3.50% | 1.77% | |
| Tata India Pharma & Healt... | Tata Mutual Fund | ₹39.26 | ₹1,565.28 Cr | 1.00% | 10.30% | 20.72% | 14.86% |
| Fund | 1Y | 3Y | Expense Ratio | Fund Size | Alpha | Sharpe | Risk | |
|---|---|---|---|---|---|---|---|---|
 Nippon India Pharma Fund - Di... | 13.21% | 19.75% | 0.99% | ₹9,479.08 Cr | 13.17 | 0.95 | Very High | |
| SBI Healthcare Opportunities ... | 22.78% | 24.99% | 1.04% | ₹5,796.42 Cr | 17.41 | 1.27 | Very High | |
 Mirae Asset Healthcare Fund -... | 22.11% | 24.02% | 0.61% | ₹3,555.18 Cr | 16.80 | 1.10 | Very High | |
| Tata India Pharma & Healthcar... | 10.30% | 20.72% | 1.00% | ₹1,565.28 Cr | 14.43 | 0.95 | Very High | |
 UTI-Healthcare Fund - Direct (G) | 18.79% | 25.04% | 1.26% | ₹1,443.57 Cr | 17.68 | 1.17 | Very High | |
 Aditya Birla SL Pharma & Heal... | 19.32% | 22.43% | 1.02% | ₹1,102.73 Cr | 16.00 | 1.10 | Very High | |
 WhiteOak Capital Pharma and H... | 24.81% | — | 1.13% | ₹902.24 Cr | 19.86 | 1.14 | Very High |